COG Cambridge Cognition Holdings Plc
Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers sensitive, precise and objective measures of cognitive function, correlated to neural networks; voice analysis, an automated speech recognition tool for monitoring neurological and psychiatric disorders; and high frequency testing that detects fluctuations in brain health with short tasks over regular timepoints. It also provides electronic questionnaires and scales (eCOA), a digital bespoke questionnaires that collects data within tight deadlines; and data quality management. Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.…
Industry Peers
Health Information ServicesKey Statistics
About Cambridge Cognition Holdings (LON: COG)
›
Cambridge Cognition Holdings (LON: COG) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 74 employees.
The shares were at 29.00 GBp on 19 November 2026, down 12.1% over 52 weeks.
Its market capitalisation is 15.65M GBP.
Cambridge Cognition Holdings reports return on equity of -55.9%, an operating margin of -10.5% and revenue up 16.9% year over year.
It holds more cash than debt, a net cash position of 349.00K GBP. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 61.67 GBp is 112.6% above the current price.